INS and metabolic dysfunction-associated steatohepatitis: A number of extra-hepatic factors are involved in the development and progression of NASH (Tilg and Moschen., 2010), and it has been shown that skeletal muscle loss (sarcopenia) and insulin resistance in skeletal muscle promote the progression of NASH via a muscle-liver axis (Bhanji et al., 2017).